- Catch-up schedule for children 4 months through 18 years shows minimum dosing interval - Related vaccine resources and websites - Automatic updates 新内容 版本记录 2024年12月20日 版本12.4.0 Minor updates. 评分及评论 5.0(满分 5 分)
the high-dose IIV has demonstrated safety and superior immunogenicity in adults aged 65 years and younger with cancer.48 In the general adult population 50-64 years of age, a recent study shows modest relative vaccine effectiveness of the high-dose recombinant vaccine against...